On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
We have now added a new section called the "Assay History List" to the "At A Gla...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...